About Axiom Therapeutics
Axiom Therapeutics is a private company based in Claymont, Delaware, incorporated in 2024 in Delaware. It has reported $12,287,219 raised in one offering on Form D since August 2026. Its chief executive is Ryan Geiser.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 25, 2026 | $12,287,219fully sold | 31 | $396K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Axiom Therapeutics's Form D filed Aug 25, 2026.